Patients with chronic lymphocytic leukemia (CLL) have high plasma-levels of Wnt5a, which can induce phosphorylation of ERK1/2 and enhance CLL-cell proliferation. This evidence concerns the gene MAPK3 and B-cell chronic lymphocytic leukemia.